NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

Core Insights - NeoGenomics will present research at ISLB 2025 demonstrating high concordance between its RaDaR ST and RaDaR 1.0 MRD assays [1] Group 1 - The presentation will include four additional posters alongside the main research findings [1]